NEW YORK (GenomeWeb News) – The Korean PCR diagnostics company Seegene will distribute Lab901’s ScreenTape system in the Korean market, Lab901 said Monday.
Under the agreement, the two companies will co-market both the ScreenTape system and Seegene’s Seeplex products in the global market, the company said.
The Seeplex products are multiplex PCR-based tests designed to detect multiple pathogens, including sexually transmitted diseases, respiratory viruses, sepsis, human papillomavirus, and pneumonia.
Lab901’s ScreenTape system is an automated system for gel electrophoresis and is used in analysis of DNA, RNA, and protein samples. The Edinburgh, UK-based company said the DS12 ScreenTape system was designed specifically for the Seeplex tests, and automates the analysis of Seegene’s PCR pathogen tests.